)

Palisade Bio (PALI) investor relations material
Palisade Bio IPO filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and business model
Clinical-stage biopharmaceutical company focused on novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, with lead candidate PALI-2108 targeting IBD, including fibrostenotic Crohn's disease and ulcerative colitis.
Precision medicine approach using biomarker-based patient selection to improve clinical response rates for PDE4 inhibitors.
Pipeline includes PALI-2108 in Phase 1b for UC and FSCD, with Phase 2 trials planned for 2026.
Strategy includes advancing clinical trials, leveraging platform for new candidates, and pursuing strategic partnerships and licensing.
Financial performance and metrics
As of June 30, 2025, pro forma as adjusted cash and cash equivalents would be $101.3 million post-offering.
Pro forma as adjusted stockholders' equity would be $98.5 million after the offering.
Historical net tangible book value per share as of June 30, 2025 was $0.55; post-offering dilution to new investors is $0.05 per share.
Company has a history of net losses and expects continued operating losses for the foreseeable future.
Use of proceeds and capital allocation
Estimated net proceeds of $92.4 million (or $106.4 million if over-allotment is exercised) based on an assumed price of $0.68 per share.
Proceeds will be used to advance PALI-2108 through preclinical and clinical development, fund R&D, and for general working capital.
Management has broad discretion over allocation of proceeds.
Next Palisade Bio earnings date

Next Palisade Bio earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage